Welcome to the
CF AMR Syndicate
Who we are
In 2019 Medicines Discovery Catapult joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR). The Syndicate recently expanded welcoming LifeArc in a tripartite managing partnership. The CF Syndicate in AMR is a cross-sector initiative which brings together leading experts in CF/AMR from industry, academia and the clinic together with people with CF.
